Legal & General Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $713K | Buy |
34,908
+8,992
| +35% | +$184K | ﹤0.01% | 2335 |
|
|
2025
Q1 | $519K | Sell |
25,916
-36
| -0.1% | -$721 | ﹤0.01% | 2386 |
|
|
2024
Q4 | $692K | Sell |
25,952
-3,168
| -11% | -$84.4K | ﹤0.01% | 2352 |
|
|
2024
Q3 | $831K | Buy |
29,120
+4,730
| +19% | +$135K | ﹤0.01% | 2294 |
|
|
2024
Q2 | $531K | Sell |
24,390
-381
| -2% | -$8.29K | ﹤0.01% | 2404 |
|
|
2024
Q1 | $549K | Sell |
24,771
-50
| -0.2% | -$1.11K | ﹤0.01% | 2388 |
|
|
2023
Q4 | $536K | Buy |
24,821
+4,457
| +22% | +$96.2K | ﹤0.01% | 2420 |
|
|
2023
Q3 | $344K | Sell |
20,364
-245
| -1% | -$4.14K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $283K | Buy |
20,609
+10,115
| +96% | +$139K | ﹤0.01% | 2650 |
|
|
2023
Q1 | $238K | Buy |
10,494
+674
| +7% | +$15.3K | ﹤0.01% | 2523 |
|
|
2022
Q4 | $231K | Hold |
9,820
| – | – | ﹤0.01% | 2552 |
|
|
2022
Q3 | $257K | Buy |
9,820
+707
| +8% | +$18.5K | ﹤0.01% | 2530 |
|
|
2022
Q2 | $200K | Sell |
9,113
-94
| -1% | -$2.06K | ﹤0.01% | 2635 |
|
|
2022
Q1 | $413K | Buy |
9,207
+223
| +2% | +$10K | ﹤0.01% | 2445 |
|
|
2021
Q4 | $385K | Buy |
8,984
+28
| +0.3% | +$1.2K | ﹤0.01% | 2494 |
|
|
2021
Q3 | $596K | Buy |
8,956
+3,894
| +77% | +$259K | ﹤0.01% | 2376 |
|
|
2021
Q2 | $372K | Buy |
5,062
+990
| +24% | +$72.8K | ﹤0.01% | 2394 |
|
|
2021
Q1 | $279K | Buy |
4,072
+2,162
| +113% | +$148K | ﹤0.01% | 2392 |
|
|
2020
Q4 | $128K | Hold |
1,910
| – | – | ﹤0.01% | 2520 |
|
|
2020
Q3 | $98K | Buy |
1,910
+219
| +13% | +$11.2K | ﹤0.01% | 2497 |
|
|
2020
Q2 | $64K | Buy |
1,691
+234
| +16% | +$8.86K | ﹤0.01% | 2653 |
|
|
2020
Q1 | $43K | Buy |
1,457
+768
| +111% | +$22.7K | ﹤0.01% | 2640 |
|
|
2019
Q4 | $24K | Buy |
689
+113
| +20% | +$3.94K | ﹤0.01% | 3129 |
|
|
2019
Q3 | $10K | Buy |
+576
| New | +$10K | ﹤0.01% | 3266 |
|